The back-to-back announcements prompted a new wave of scepticism towards the company, and HRT stock fell more than 12% on 22 July, as investors fear the company will follow the same path as troubled OGX.
“Both HRT and OGX are suffering credibility crises because of their overly hyped pre-drill estimates. Without a proper cash flow and being very indebted, the two are having difficulties to continue their investment plans.
